Table of Content

1 Market Overview of Neurology Clinical Trial
1.1 Neurology Clinical Trial Market Overview
1.1.1 Neurology Clinical Trial Product Scope
1.1.2 Neurology Clinical Trial Market Status and Outlook
1.2 Global Neurology Clinical Trial Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Neurology Clinical Trial Market Size by Region (2018-2033)
1.4 Global Neurology Clinical Trial Historic Market Size by Region (2018-2023)
1.5 Global Neurology Clinical Trial Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Neurology Clinical Trial Market Size (2018-2033)
1.6.1 North America Neurology Clinical Trial Market Size (2018-2033)
1.6.2 Europe Neurology Clinical Trial Market Size (2018-2033)
1.6.3 Asia-Pacific Neurology Clinical Trial Market Size (2018-2033)
1.6.4 Latin America Neurology Clinical Trial Market Size (2018-2033)
1.6.5 Middle East & Africa Neurology Clinical Trial Market Size (2018-2033)
2 Neurology Clinical Trial Market by Type
2.1 Introduction
2.1.1 Bone Marrow
2.1.2 Epidermis
2.1.3 Mesenchymal Stem Cells
2.1.4 Haematopoietic Stem Cells
2.1.5 Chondrocytes
2.2 Global Neurology Clinical Trial Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Neurology Clinical Trial Historic Market Size by Type (2018-2023)
2.2.2 Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Neurology Clinical Trial Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Neurology Clinical Trial Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Neurology Clinical Trial Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Neurology Clinical Trial Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Neurology Clinical Trial Revenue Breakdown by Type (2018-2033)
3 Neurology Clinical Trial Market Overview by Application
3.1 Introduction
3.1.1 Neurodegenerative Disorders
3.1.2 Cardiovascular Disorders
3.1.3 Orthopedics
3.1.4 Wound Healing
3.1.5 Other
3.2 Global Neurology Clinical Trial Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Neurology Clinical Trial Historic Market Size by Application (2018-2023)
3.2.2 Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Neurology Clinical Trial Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Neurology Clinical Trial Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Neurology Clinical Trial Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Neurology Clinical Trial Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Neurology Clinical Trial Revenue Breakdown by Application (2018-2033)
4 Neurology Clinical Trial Competition Analysis by Players
4.1 Global Neurology Clinical Trial Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
4.3 Date of Key Players Enter into Neurology Clinical Trial Market
4.4 Global Top Players Neurology Clinical Trial Headquarters and Area Served
4.5 Key Players Neurology Clinical Trial Product Solution and Service
4.6 Competitive Status
4.6.1 Neurology Clinical Trial Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BrainStorm Cell Therapeutics
5.1.1 BrainStorm Cell Therapeutics Profile
5.1.2 BrainStorm Cell Therapeutics Main Business
5.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Products, Services and Solutions
5.1.4 BrainStorm Cell Therapeutics Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.1.5 BrainStorm Cell Therapeutics Recent Developments
5.2 Opexa Therapeutics
5.2.1 Opexa Therapeutics Profile
5.2.2 Opexa Therapeutics Main Business
5.2.3 Opexa Therapeutics Neurology Clinical Trial Products, Services and Solutions
5.2.4 Opexa Therapeutics Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.2.5 Opexa Therapeutics Recent Developments
5.3 Caladrius Biosciences
5.3.1 Caladrius Biosciences Profile
5.3.2 Caladrius Biosciences Main Business
5.3.3 Caladrius Biosciences Neurology Clinical Trial Products, Services and Solutions
5.3.4 Caladrius Biosciences Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.3.5 U.S. Stem Cell Recent Developments
5.4 U.S. Stem Cell
5.4.1 U.S. Stem Cell Profile
5.4.2 U.S. Stem Cell Main Business
5.4.3 U.S. Stem Cell Neurology Clinical Trial Products, Services and Solutions
5.4.4 U.S. Stem Cell Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.4.5 U.S. Stem Cell Recent Developments
5.5 Lonza
5.5.1 Lonza Profile
5.5.2 Lonza Main Business
5.5.3 Lonza Neurology Clinical Trial Products, Services and Solutions
5.5.4 Lonza Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.5.5 Lonza Recent Developments
5.6 Bristol Myers Squibb
5.6.1 Bristol Myers Squibb Profile
5.6.2 Bristol Myers Squibb Main Business
5.6.3 Bristol Myers Squibb Neurology Clinical Trial Products, Services and Solutions
5.6.4 Bristol Myers Squibb Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol Myers Squibb Recent Developments
5.7 Corning Incorporated
5.7.1 Corning Incorporated Profile
5.7.2 Corning Incorporated Main Business
5.7.3 Corning Incorporated Neurology Clinical Trial Products, Services and Solutions
5.7.4 Corning Incorporated Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.7.5 Corning Incorporated Recent Developments
5.8 Vericel Corporation
5.8.1 Vericel Corporation Profile
5.8.2 Vericel Corporation Main Business
5.8.3 Vericel Corporation Neurology Clinical Trial Products, Services and Solutions
5.8.4 Vericel Corporation Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.8.5 Vericel Corporation Recent Developments
5.9 Catalent
5.9.1 Catalent Profile
5.9.2 Catalent Main Business
5.9.3 Catalent Neurology Clinical Trial Products, Services and Solutions
5.9.4 Catalent Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.9.5 Catalent Recent Developments
5.10 Lineage Cell Therapeutics
5.10.1 Lineage Cell Therapeutics Profile
5.10.2 Lineage Cell Therapeutics Main Business
5.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Products, Services and Solutions
5.10.4 Lineage Cell Therapeutics Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.10.5 Lineage Cell Therapeutics Recent Developments
5.11 Castle Creek Biosciences
5.11.1 Castle Creek Biosciences Profile
5.11.2 Castle Creek Biosciences Main Business
5.11.3 Castle Creek Biosciences Neurology Clinical Trial Products, Services and Solutions
5.11.4 Castle Creek Biosciences Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.11.5 Castle Creek Biosciences Recent Developments
5.12 Sangamo Therapeutics
5.12.1 Sangamo Therapeutics Profile
5.12.2 Sangamo Therapeutics Main Business
5.12.3 Sangamo Therapeutics Neurology Clinical Trial Products, Services and Solutions
5.12.4 Sangamo Therapeutics Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.12.5 Sangamo Therapeutics Recent Developments
5.13 Novartis
5.13.1 Novartis Profile
5.13.2 Novartis Main Business
5.13.3 Novartis Neurology Clinical Trial Products, Services and Solutions
5.13.4 Novartis Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.13.5 Novartis Recent Developments
5.14 Holostem Terapie Avanzate S.R.L
5.14.1 Holostem Terapie Avanzate S.R.L Profile
5.14.2 Holostem Terapie Avanzate S.R.L Main Business
5.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Products, Services and Solutions
5.14.4 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.14.5 Holostem Terapie Avanzate S.R.L Recent Developments
5.15 Pharmicell
5.15.1 Pharmicell Profile
5.15.2 Pharmicell Main Business
5.15.3 Pharmicell Neurology Clinical Trial Products, Services and Solutions
5.15.4 Pharmicell Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.15.5 Pharmicell Recent Developments
5.16 Tego Science
5.16.1 Tego Science Profile
5.16.2 Tego Science Main Business
5.16.3 Tego Science Neurology Clinical Trial Products, Services and Solutions
5.16.4 Tego Science Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.16.5 Tego Science Recent Developments
5.17 Autolus therapeutics
5.17.1 Autolus therapeutics Profile
5.17.2 Autolus therapeutics Main Business
5.17.3 Autolus therapeutics Neurology Clinical Trial Products, Services and Solutions
5.17.4 Autolus therapeutics Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.17.5 Autolus therapeutics Recent Developments
5.18 Bayer AG
5.18.1 Bayer AG Profile
5.18.2 Bayer AG Main Business
5.18.3 Bayer AG Neurology Clinical Trial Products, Services and Solutions
5.18.4 Bayer AG Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.18.5 Bayer AG Recent Developments
5.19 Sartorius AG
5.19.1 Sartorius AG Profile
5.19.2 Sartorius AG Main Business
5.19.3 Sartorius AG Neurology Clinical Trial Products, Services and Solutions
5.19.4 Sartorius AG Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.19.5 Sartorius AG Recent Developments
5.20 Daiichi Sankyo
5.20.1 Daiichi Sankyo Profile
5.20.2 Daiichi Sankyo Main Business
5.20.3 Daiichi Sankyo Neurology Clinical Trial Products, Services and Solutions
5.20.4 Daiichi Sankyo Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.20.5 Daiichi Sankyo Recent Developments
5.21 Takeda Pharmaceutical Company
5.21.1 Takeda Pharmaceutical Company Profile
5.21.2 Takeda Pharmaceutical Company Main Business
5.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Products, Services and Solutions
5.21.4 Takeda Pharmaceutical Company Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.21.5 Takeda Pharmaceutical Company Recent Developments
5.22 Sumitomo Chemical Co
5.22.1 Sumitomo Chemical Co Profile
5.22.2 Sumitomo Chemical Co Main Business
5.22.3 Sumitomo Chemical Co Neurology Clinical Trial Products, Services and Solutions
5.22.4 Sumitomo Chemical Co Neurology Clinical Trial Revenue (US$ Million) & (2018-2023)
5.22.5 Sumitomo Chemical Co Recent Developments
6 North America
6.1 North America Neurology Clinical Trial Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neurology Clinical Trial Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neurology Clinical Trial Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neurology Clinical Trial Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neurology Clinical Trial Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neurology Clinical Trial Market Dynamics
11.1 Neurology Clinical Trial Industry Trends
11.2 Neurology Clinical Trial Market Drivers
11.3 Neurology Clinical Trial Market Challenges
11.4 Neurology Clinical Trial Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Neurology Clinical Trial Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Neurology Clinical Trial Market Size Share by Region (2018-2023)
Table 4. Global Neurology Clinical Trial Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Neurology Clinical Trial Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Neurology Clinical Trial Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Neurology Clinical Trial Revenue Market Share by Type (2018-2023)
Table 9. Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Neurology Clinical Trial Revenue Market Share by Type (2024-2033)
Table 11. North America Neurology Clinical Trial Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Neurology Clinical Trial Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Neurology Clinical Trial Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Neurology Clinical Trial Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Neurology Clinical Trial Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Neurology Clinical Trial Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Neurology Clinical Trial Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Neurology Clinical Trial Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Neurology Clinical Trial Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Neurology Clinical Trial Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Neurology Clinical Trial Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Neurology Clinical Trial Revenue Market Share by Application (2018-2023)
Table 24. Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Neurology Clinical Trial Revenue Market Share by Application (2024-2033)
Table 26. North America Neurology Clinical Trial Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Neurology Clinical Trial Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Neurology Clinical Trial Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Neurology Clinical Trial Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Neurology Clinical Trial Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Neurology Clinical Trial Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Neurology Clinical Trial Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Neurology Clinical Trial Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Neurology Clinical Trial Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Neurology Clinical Trial Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Neurology Clinical Trial Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Neurology Clinical Trial Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
Table 39. Date of Key Players Enter into Neurology Clinical Trial Market
Table 40. Global Neurology Clinical Trial Key Players Headquarters and Area Served
Table 41. Neurology Clinical Trial Product Solution and Service
Table 42. Global Neurology Clinical Trial Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. BrainStorm Cell Therapeutics Basic Information List
Table 45. BrainStorm Cell Therapeutics Description and Business Overview
Table 46. BrainStorm Cell Therapeutics Neurology Clinical Trial Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neurology Clinical Trial Business of BrainStorm Cell Therapeutics (2018-2023)
Table 48. BrainStorm Cell Therapeutics Recent Developments
Table 49. Opexa Therapeutics Basic Information List
Table 50. Opexa Therapeutics Description and Business Overview
Table 51. Opexa Therapeutics Neurology Clinical Trial Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neurology Clinical Trial Business of Opexa Therapeutics (2018-2023)
Table 53. Opexa Therapeutics Recent Developments
Table 54. Caladrius Biosciences Basic Information List
Table 55. Caladrius Biosciences Description and Business Overview
Table 56. Caladrius Biosciences Neurology Clinical Trial Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neurology Clinical Trial Business of Caladrius Biosciences (2018-2023)
Table 58. Caladrius Biosciences Recent Developments
Table 59. U.S. Stem Cell Basic Information List
Table 60. U.S. Stem Cell Description and Business Overview
Table 61. U.S. Stem Cell Neurology Clinical Trial Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neurology Clinical Trial Business of U.S. Stem Cell (2018-2023)
Table 63. U.S. Stem Cell Recent Developments
Table 64. Lonza Basic Information List
Table 65. Lonza Description and Business Overview
Table 66. Lonza Neurology Clinical Trial Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neurology Clinical Trial Business of Lonza (2018-2023)
Table 68. Lonza Recent Developments
Table 69. Bristol Myers Squibb Basic Information List
Table 70. Bristol Myers Squibb Description and Business Overview
Table 71. Bristol Myers Squibb Neurology Clinical Trial Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neurology Clinical Trial Business of Bristol Myers Squibb (2018-2023)
Table 73. Bristol Myers Squibb Recent Developments
Table 74. Corning Incorporated Basic Information List
Table 75. Corning Incorporated Description and Business Overview
Table 76. Corning Incorporated Neurology Clinical Trial Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neurology Clinical Trial Business of Corning Incorporated (2018-2023)
Table 78. Corning Incorporated Recent Developments
Table 79. Vericel Corporation Basic Information List
Table 80. Vericel Corporation Description and Business Overview
Table 81. Vericel Corporation Neurology Clinical Trial Products, Services and Solutions
Table 82. Revenue (US$ Million) in Neurology Clinical Trial Business of Vericel Corporation (2018-2023)
Table 83. Vericel Corporation Recent Developments
Table 84. Catalent Basic Information List
Table 85. Catalent Description and Business Overview
Table 86. Catalent Neurology Clinical Trial Products, Services and Solutions
Table 87. Revenue (US$ Million) in Neurology Clinical Trial Business of Catalent (2018-2023)
Table 88. Catalent Recent Developments
Table 89. Lineage Cell Therapeutics Basic Information List
Table 90. Lineage Cell Therapeutics Description and Business Overview
Table 91. Lineage Cell Therapeutics Neurology Clinical Trial Products, Services and Solutions
Table 92. Revenue (US$ Million) in Neurology Clinical Trial Business of Lineage Cell Therapeutics (2018-2023)
Table 93. Lineage Cell Therapeutics Recent Developments
Table 94. Castle Creek Biosciences Basic Information List
Table 95. Castle Creek Biosciences Description and Business Overview
Table 96. Castle Creek Biosciences Neurology Clinical Trial Products, Services and Solutions
Table 97. Revenue (US$ Million) in Neurology Clinical Trial Business of Castle Creek Biosciences (2018-2023)
Table 98. Castle Creek Biosciences Recent Developments
Table 99. Sangamo Therapeutics Basic Information List
Table 100. Sangamo Therapeutics Description and Business Overview
Table 101. Sangamo Therapeutics Neurology Clinical Trial Products, Services and Solutions
Table 102. Revenue (US$ Million) in Neurology Clinical Trial Business of Sangamo Therapeutics (2018-2023)
Table 103. Sangamo Therapeutics Recent Developments
Table 104. Novartis Basic Information List
Table 105. Novartis Description and Business Overview
Table 106. Novartis Neurology Clinical Trial Products, Services and Solutions
Table 107. Revenue (US$ Million) in Neurology Clinical Trial Business of Novartis (2018-2023)
Table 108. Novartis Recent Developments
Table 109. Holostem Terapie Avanzate S.R.L Basic Information List
Table 110. Holostem Terapie Avanzate S.R.L Description and Business Overview
Table 111. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Products, Services and Solutions
Table 112. Revenue (US$ Million) in Neurology Clinical Trial Business of Holostem Terapie Avanzate S.R.L (2018-2023)
Table 113. Holostem Terapie Avanzate S.R.L Recent Developments
Table 114. Pharmicell Basic Information List
Table 115. Pharmicell Description and Business Overview
Table 116. Pharmicell Neurology Clinical Trial Products, Services and Solutions
Table 117. Revenue (US$ Million) in Neurology Clinical Trial Business of Pharmicell (2018-2023)
Table 118. Pharmicell Recent Developments
Table 119. Tego Science Basic Information List
Table 120. Tego Science Description and Business Overview
Table 121. Tego Science Neurology Clinical Trial Products, Services and Solutions
Table 122. Revenue (US$ Million) in Neurology Clinical Trial Business of Tego Science (2018-2023)
Table 123. Tego Science Recent Developments
Table 124. Autolus therapeutics Basic Information List
Table 125. Autolus therapeutics Description and Business Overview
Table 126. Autolus therapeutics Neurology Clinical Trial Products, Services and Solutions
Table 127. Revenue (US$ Million) in Neurology Clinical Trial Business of Autolus therapeutics (2018-2023)
Table 128. Autolus therapeutics Recent Developments
Table 129. Bayer AG Basic Information List
Table 130. Bayer AG Description and Business Overview
Table 131. Bayer AG Neurology Clinical Trial Products, Services and Solutions
Table 132. Revenue (US$ Million) in Neurology Clinical Trial Business of Bayer AG (2018-2023)
Table 133. Bayer AG Recent Developments
Table 134. Sartorius AG Basic Information List
Table 135. Sartorius AG Description and Business Overview
Table 136. Sartorius AG Neurology Clinical Trial Products, Services and Solutions
Table 137. Revenue (US$ Million) in Neurology Clinical Trial Business of Sartorius AG (2018-2023)
Table 138. Sartorius AG Recent Developments
Table 139. Daiichi Sankyo Basic Information List
Table 140. Daiichi Sankyo Description and Business Overview
Table 141. Daiichi Sankyo Neurology Clinical Trial Products, Services and Solutions
Table 142. Revenue (US$ Million) in Neurology Clinical Trial Business of Daiichi Sankyo (2018-2023)
Table 143. Daiichi Sankyo Recent Developments
Table 144. Takeda Pharmaceutical Company Basic Information List
Table 145. Takeda Pharmaceutical Company Description and Business Overview
Table 146. Takeda Pharmaceutical Company Neurology Clinical Trial Products, Services and Solutions
Table 147. Revenue (US$ Million) in Neurology Clinical Trial Business of Takeda Pharmaceutical Company (2018-2023)
Table 148. Takeda Pharmaceutical Company Recent Developments
Table 149. Sumitomo Chemical Co Basic Information List
Table 150. Sumitomo Chemical Co Description and Business Overview
Table 151. Sumitomo Chemical Co Neurology Clinical Trial Products, Services and Solutions
Table 152. Revenue (US$ Million) in Neurology Clinical Trial Business of Sumitomo Chemical Co (2018-2023)
Table 153. Sumitomo Chemical Co Recent Developments
Table 154. North America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 155. North America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 156. Europe Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 157. Europe Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 158. Asia-Pacific Neurology Clinical Trial Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 159. Asia-Pacific Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 160. Asia-Pacific Neurology Clinical Trial Market Size by Region (2024-2033) & (US$ Million)
Table 161. Asia-Pacific Neurology Clinical Trial Market Share by Region (2018-2023)
Table 162. Asia-Pacific Neurology Clinical Trial Market Share by Region (2024-2033)
Table 163. Latin America Neurology Clinical Trial Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 164. Latin America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 165. Latin America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 166. Middle East & Africa Neurology Clinical Trial Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 167. Middle East & Africa Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 168. Middle East & Africa Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 169. Neurology Clinical Trial Market Trends
Table 170. Neurology Clinical Trial Market Drivers
Table 171. Neurology Clinical Trial Market Challenges
Table 172. Neurology Clinical Trial Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurology Clinical Trial Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Neurology Clinical Trial Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Neurology Clinical Trial Market Share by Regions: 2022 VS 2033
Figure 4. Global Neurology Clinical Trial Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Neurology Clinical Trial Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Neurology Clinical Trial Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Neurology Clinical Trial Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Neurology Clinical Trial Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Neurology Clinical Trial Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Bone Marrow
Figure 11. Global Bone Marrow Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Epidermis
Figure 13. Global Epidermis Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Mesenchymal Stem Cells
Figure 15. Global Mesenchymal Stem Cells Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Haematopoietic Stem Cells
Figure 17. Global Haematopoietic Stem Cells Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Chondrocytes
Figure 19. Global Chondrocytes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Neurology Clinical Trial Market Size Share by Type: 2022 & 2033
Figure 21. North America Neurology Clinical Trial Revenue Market Share by Type (2018-2033)
Figure 22. Europe Neurology Clinical Trial Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Neurology Clinical Trial Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Neurology Clinical Trial Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Neurology Clinical Trial Revenue Market Share by Type (2018-2033)
Figure 26. Neurodegenerative Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Cardiovascular Disorders Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Orthopedics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Wound Healing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 30. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 31. Global Neurology Clinical Trial Market Size Share by Application: 2022 & 2033
Figure 32. North America Neurology Clinical Trial Revenue Market Share by Application (2018-2033)
Figure 33. Europe Neurology Clinical Trial Revenue Market Share by Application (2018-2033)
Figure 34. Asia-Pacific Neurology Clinical Trial Revenue Market Share by Application (2018-2033)
Figure 35. Latin America Neurology Clinical Trial Revenue Market Share by Application (2018-2033)
Figure 36. Middle East and Africa Neurology Clinical Trial Revenue Market Share by Application (2018-2033)
Figure 37. Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 38. Global Top 5 and Top 10 Players Neurology Clinical Trial Market Share in 2022
Figure 39. North America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 40. United States Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 41. Canada Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 42. Germany Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 43. France Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 44. U.K. Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 45. Italy Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 46. Russia Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 47. Nordic Countries Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 48. Asia-Pacific Neurology Clinical Trial Market Share by Region (2018-2033)
Figure 49. China Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 50. Japan Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 51. South Korea Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 53. India Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 54. Australia Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 55. Latin America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 56. Mexico Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 57. Brazil Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 58. Middle East & Africa Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 59. Turkey Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 60. Saudi Arabia Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 61. UAE Neurology Clinical Trial Market Size (2018-2033) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report